Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. India Malaria Vaccine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Others),
5.2.2. By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others)
5.2.3. By Region
5.2.4. By Company (2022)
6. North-India Malaria Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Vaccine Type
6.2.2. By Route of Administration
7. South-India Malaria Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Vaccine Type
7.2.2. By Route of Administration
8. East India Malaria Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Vaccine Type
8.2.2. By Route of Administration
9. West India Malaria Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Vaccine Type
9.2.2. By Route of Administration
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Competitive Landscape
12.1. Business Overview
12.2. Service Offerings
12.3. Recent Developments
12.4. Financials (As Reported)
12.5. Key Personnel
12.6. SWOT Analysis
12.6.1. Gennova Biopharmaceuticals Ltd
12.6.2. Zydus Group
12.6.3. Serum Institute of India Private Limited
12.6.4. Bharat Biotech International Limited
12.6.5. Indian Immunologicals Limited
12.6.6. Panacea Biotec
12.6.7. Mynvax
12.6.8. Cadila Pharmaceuticals
12.6.9. Biological E Limited
12.6.10. Sanofi Pasteur
13. Strategic Recommendations